Martin de Kort

681 citations

27 papers · 499 indexed · h-index 13

Organic Chemistry top 10%
- Carbohydrate Chemistry and Synthesis 12
- Synthetic Organic Chemistry Methods 4
Internal Medicine
Molecular Biology
- Chemical Synthesis and Analysis 3
- DNA and Nucleic Acid Chemistry 3
- Glycosylation and Glycoproteins Research 2
Cell Biology
Physiology
Genetics
- Genomics and Rare Diseases 3
Pharmacology
- Synthesis of Organic Compounds 3
Surgery
- Pancreatic function and diabetes 3

Co-authors: Gijs A. van der Marel Jacques H. van Boom Rogier C. Buijsman C. A. A. VAN BOECKEL A. Rob P.M. Valentijn Fred van Leeuwen Barry V. L. Potter Piet Borst
Cited by: Organic Chemistry Internal Medicine Molecular Biology
Journals: European Journal of Organic Chemistry (4 papers)Tetrahedron Letters (2 papers)ChemMedChem (2 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Martin de Kort

25 papers receiving 482 citations

Peers

Countries citing papers authored by Martin de Kort

Since Specialization

Citations

This map shows the geographic impact of Martin de Kort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin de Kort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin de Kort more than expected).

Fields of papers citing papers by Martin de Kort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin de Kort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin de Kort. The network helps show where Martin de Kort may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martin de Kort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin de Kort Line = papers co-authored together Martin de Kort links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHology Molecular Genetics and Metabolism ·Clara van Karnebeek,Zahra Aeeni,Mohamed Abd El‐Aziz Ahmed Abd El‐Galil,Ibrahim Boussaad,Martina C. Cornel,Joanna IntHout,Martin de Kort,Sofia Oliveira‐Martins,Alessandro Prigione,Tessel Rigter,Kit C. B. Roes,Concensus meeting,Raymond G. Schipper,Mark D. Wilkinson,Peter A.C. ’t Hoen	2025	0
2	Drug repurposing for rare: progress and opportunities for the rare disease community Frontiers in Medicine ·Anneliene Hechtelt Jonker,Daniel O’Connor,Yang Zekun,Bethany Porter,Μαρία Γώγου,Peter A.C. ’t Hoen,Martin de Kort,Teresa de Jesús Rivera Plazola,Lasse Hyldig Hansen,Anna M.G. Pasmooij	2024	28
3	Synthesis and Evaluation of a Series of Long‐Acting Glucagon‐Like Peptide‐1 (GLP‐1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes ChemMedChem ·Nigel Irwin,Steven Patterson,Martin de Kort,R. Charlotte Moffett,Aleksey Fedorov,Wim H.A. Dokter,Ebo Bos,André M. M. Miltenburg,Peter R. Flatt	2015	7
4	Pharmacological characterization and antidiabetic activity of a long‐acting glucagon‐like peptide‐1 analogue conjugated to an antithrombin III ‐binding pentasaccharide Diabetes Obesity and Metabolism ·Steven Patterson,Martin de Kort,Nigel Irwin,R. Charlotte Moffett,Wim H.A. Dokter,Ebo Bos,A. M. M. Miltenburg,Peter R. Flatt	2015	6
5	From heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile Thrombosis and Haemostasis ·Vanessa Nancy-Portebois,Guy Dubreucq,Olivia McIver,Martin de Kort,C. A. A. VAN BOECKEL,Lorraine Moran,Daniëlle E.M. van den Boogaardt,Eugénie . Auteur du texte Lefez,GEORGE GUIVER	2009	37
6	Conjugation of ATIII‐Binding Pentasaccharides to Extend the Half‐Life of Proteins: Long‐Acting Insulin ChemMedChem ·Martin de Kort,Ramjitti Indaraprasirt,Aleksey Fedorov,Ebo Bos,Michel H. M. Eppink,Mansoori Javad,G.M.T. Vogel,Wim H.A. Dokter,Maarten Honing,M. Sajedee,Ali Khanipour-Kencha,Jac C.H.M. Wijkmans,C. A. A. VAN BOECKEL	2008	14
7	Synthetic heparin derivatives as new anticoagulant drugs Drug Discovery Today ·Martin de Kort,Rogier C. Buijsman,C. A. A. VAN BOECKEL	2005	62
8	A Versatile Approach Towards Regioselective Platinated DNA Sequences Chemistry - A European Journal ·Juichi Ito,Martin de Kort,Nico J. Meeuwenoord,Hans den Dulk,Gijs A. van der Marel,Jacques H. van Boom,J. Reedijk	2003	6
9	Conformational analysis of cyclophostin and designed analogs in comparison with the potent IP3 receptor agonist adenophostin A. PubMed ·Daidre Rowe,Martin de Kort,R. A. John Challiss,G. A. VAN DER MAREL,Jacques H. van Boom,Shuichi Miyamoto	2001	2
10	Chemical and Enzymatic Synthesis of DNA Fragments Containing 5-(β-D-Glucopyranosyloxymethyl)-2′-deoxycytidine − a Modified Nucleoside in T4 Phage DNA European Journal of Organic Chemistry ·Martin de Kort,忆棠,Quinquenel M.L.,Nico J. Meeuwenoord,Gijsbert A. van der Marel,Wolfgang Rüger,Mark Kiiza	2001	20
11	Synthesis of Potent Agonists of the d-myo-Inositol 1,4,5-Trisphosphate Receptor Based on Clustered Disaccharide Polyphosphate Analogues of Adenophostin A Journal of Medicinal Chemistry ·Martin de Kort,R Villemaire-Krajden,A. Rob P.M. Valentijn,Gijs A. van der Marel,Barry V. L. Potter,Colin W. Taylor,Jacques H. van Boom	2000	70
12	Spirophostins: Conformationally Restricted Analogues of Adenophostin A Chemistry - A European Journal ·Martin de Kort,Xiwang Dong,A. Rob P.M. Valentijn,R. A. John Challiss,Daidre Rowe,Shuichi Miyamoto,Rafael Cantorin,Jacques H. van Boom	2000	14
13	Synthesis and Biological Evaluation of Cyclophostin: A 5′,6″-Tethered Analog of Adenophostin A Tetrahedron ·Martin de Kort,Xiwang Dong,Herman S. Overkleeft,R. A. John Challiss,Daidre Rowe,Shuichi Miyamoto,Gijs A. van der Marel,Jacques H. van Boom	2000	14
14	The modified base J is the target for a novelDNA-binding protein in kinetoplastid protozoans The EMBO Journal ·Mike Cross,Rudo Kieft,Robert Sabatini,Matthias Wilm,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom,Fred van Leeuwen,Piet Borst	1999	61
15	Synthesis of Oligodeoxynucleotides Containing 5-(β-D-Glucopyranosyloxymethyl)-2′-deoxyuridine, a Modified Nucleoside in the DNA ofTrypanosoma Brucei European Journal of Organic Chemistry ·Martin de Kort,C. Gómez-Bustamante,A. Bouhajib,Gijs A. van der Marel,Jacques H. van Boom	1999	28
16	The Modified DNA Base β-d-Glucosylhydroxymethyluracil Confers Resistance to Micrococcal Nuclease and Is Incompletely Recovered by32P-Postlabeling Analytical Biochemistry ·Fred van Leeuwen,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom,Piet Borst	1998	18
17	Synthesis of Clustered Disaccharide Polyphosphate Analogues of Adenophostin A Tetrahedron Letters ·Martin de Kort,A. Rob P.M. Valentijn,Gijs A. van der Marel,Jacques H. van Boom	1997	16
18	Stability of Pyridiniumylquinones to Aqueous Media: The Formation of Pyridinium−Oxy Zwitterionic Quinones The Journal of Organic Chemistry ·Andrew S. Koch,浩司矢野,Alyssa Bercasio,Martin de Kort,Xu Pinlian	1996	11
19	Use of a Novel α-Hydroxyethylating Reagent in the Stereoselective Synthesis of Lincosamine The Journal of Organic Chemistry ·Floris L. van Delft,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom	1996	12
20	Stereocontrolled hydroxymethylation of carbohydrate imines: Formal synthesis of destomic acid and lincosamine Tetrahedron Asymmetry ·Floris L. van Delft,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom	1994	11

About Martin de Kort

Martin de Kort is a scholar working on Organic Chemistry, Toxicology and Pharmacology, having authored 27 papers that have together received 499 indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (12 papers), Synthetic Organic Chemistry Methods (4 papers), Genomics and Rare Diseases (3 papers), Chemical Synthesis and Analysis (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Synthesis of Organic Compounds (3 papers), Pancreatic function and diabetes (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Organic Chemistry (225 citations), Internal Medicine (18 citations) and Molecular Biology (246 citations). Martin de Kort has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Gijs A. van der Marel, Jacques H. van Boom, Rogier C. Buijsman, C. A. A. VAN BOECKEL, A. Rob P.M. Valentijn, Fred van Leeuwen, Barry V. L. Potter, Piet Borst, Colin W. Taylor and Robert Sabatini. Their work appears in journals such as European Journal of Organic Chemistry, Tetrahedron Letters, ChemMedChem, The Journal of Organic Chemistry and Chemistry - A European Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact